Form 4: Boston Scientific Director Charles J. Dockendorff Reports Stock Sale Under 10b5-1 Plan

Director Charles J. Dockendorff of Boston Scientific Corp. reports the sale of 3,946 shares of common stock at $72.70 per share under a pre-established Rule 10b5-1 trading plan.

Summary

• Charles J. Dockendorff, a director of Boston Scientific Corp., filed a Form 4 disclosing a transaction involving the company's common stock.
• On May 7, 2024, Dockendorff sold 3,946 shares of common stock at a price of $72.70 per share.
• The sale was executed under a pre-established Rule 10b5-1 trading plan adopted on May 19, 2023.
• Following the transaction, Dockendorff directly owns no shares of common stock.
• Dockendorff indirectly owns 42,622 shares through a spouse's trust and 17,380 shares through another trust.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports a pre-planned stock sale by a director under a 10b5-1 trading plan. There is no indication of positive or negative implications for the company.

Industry Context

Sales by insiders are a normal part of corporate governance. The use of a 10b5-1 plan suggests the sale was pre-planned and not based on any specific non-public information.

Key Dates